findmyKOL

Joseph Vassalotti, MD

Basic profile

National Kidney Foundation

ORCID↗NPI↗
✓ Full record
RegionNew York, NY · NortheastSpecialtyNephrologyFocusNephrology
Active KOLEmergingfindmyKOL type: RegionalLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Joseph Vassalotti is a Nephrology physician affiliated with National Kidney Foundation. OpenAlex indexes 205 publications with 7,687 citations (h-index 42).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
205publications

Distinct works indexed by OpenAlex, matched via ORCID.

7,687citations

Total citations across indexed works.

42h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
7companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

5 East 98th Street Box 1118
Mount Sinai Faculty Practice Associates
New York, NY 10029

Telephone

212-241-4060

Registry record last updated 28 Mar 2012.

View the NPPES registry record

Industry payments

7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    65.1%
    Angiotensin receptor blocker (ARB)23.2%
    Losartan Potassium64%Olmesartan Medoxomil19%Candesartan Cilexetil17%
    Part D<11 patients
    Statin8.8%
    Atorvastatin Calcium80%Rosuvastatin Calcium20%
    Part D<11 patients

    + 7 more classes in this area

  • Metabolism & gastrointestinal

    18.7%
    SGLT2 inhibitor12.8%
    Jardiance61%Farxiga39%
    Part D≥17 patients
    H2 blocker3.2%
    Famotidine100%
    Part D<11 patients

    + 1 more class in this area

  • Other

    6.5%
    Drugs for treatment of hyperkalemia and hyperphosphatemia3.2%
    Lokelma100%
    Part D<11 patients
    Potassium Binder3.2%
    Sodium Polystyrene Sulfonate100%
    Part D<11 patients
Where care is delivered (Part B)19.4% facility · 80.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”